DKL-25106-28249
4 vaccinations
10 coded responses
49 check-ins
10 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 972 / OR
- Registered
- 2020-12-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-17
Dose 1 — Pfizer-BioNTech
-
2020-12-18
Registered in v-safe
-
2020-12-18
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2020-12-19
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-24
- 2020-12-31
-
2021-01-07
Dose 2 — Pfizer-BioNTech
- 2021-01-07
-
2021-01-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-08
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-09
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Muscle or body achesFree text: Painful Axillary lymphadenopathy in the injection armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Lymphadenopathy — Feeling: Good · Site: PainFree text: Improving painful axillary lymphadenopathy in the injection armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-12
Survey response — days 1–6 daily, dose 2MedDRA: Axillary pain, Lymphadenopathy — Feeling: GoodFree text: Slowly improving axillary pain and lymphadenopathy in the injection armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-14
Survey response — day 7, dose 2MedDRA: Axillary pain, Lymphadenopathy — Feeling: GoodFree text: Mild axillary pain, resolving lymphadenopathy in injection armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-21
- 2021-01-28
- 2021-02-04
- 2021-02-11
- 2021-02-18
- 2021-04-08
- 2021-07-08
-
2021-09-27
Dose 3 — Pfizer-BioNTech
- 2021-09-27
-
2021-09-28
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-09-30
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tirednessFree text: Axillary lymphadenopathy in shot arm (left) and mildly in right arm (site of prior shots)MedDRA releases: 2024-11 · check-in free text available
-
2021-10-01
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Axillary Lymphadenopathy in shot armMedDRA releases: 2024-11 · check-in free text available
-
2021-10-02
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: GoodFree text: Improving lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-10
- 2021-12-27
- 2022-03-29
-
2022-09-26
Dose 4 — Pfizer-BioNTechCo-administered: Flu:Other
- 2022-09-26
-
2022-09-27
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-09-28
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain, Redness, Swelling · Muscle or body aches, Fatigue or tirednessFree text: Axillary Lymphadenopathy in shot armMedDRA releases: 2024-11 · check-in free text available
-
2022-09-29
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Ipsilateral axillary lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
-
2022-10-01
Survey response — days 1–6 daily, dose 4MedDRA: Lymphadenopathy — Feeling: GoodFree text: Improved ipsilateral lymphadenopathyMedDRA releases: 2024-11 · check-in free text available
- 2022-10-02
- 2022-10-03
- 2022-10-10
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-12-26
- 2023-03-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-17 | Pfizer-BioNTech | |
| 2 | 2021-01-07 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-09-26 | Pfizer-BioNTech | Flu:Other |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Painful Axillary lymphadenopathy in the injection arm
Systemic reaction (other): Improving painful axillary lymphadenopathy in the injection arm
Systemic reaction (other): Slowly improving axillary pain and lymphadenopathy in the injection arm
Release 2 — day 7, dose 2
Systemic reaction (other): Mild axillary pain, resolving lymphadenopathy in injection arm
Release 9 — days 1–6 daily, dose 3
Systemic reaction (other): Axillary lymphadenopathy in shot arm (left) and mildly in right arm (site of prior shots)
Systemic reaction (other): Axillary Lymphadenopathy in shot arm
Systemic reaction (other): Improving lymphadenopathy
Release 12 — days 1–6 daily, dose 4
Systemic reaction (other): Axillary Lymphadenopathy in shot arm
Systemic reaction (other): Ipsilateral axillary lymphadenopathy
Systemic reaction (other): Improved ipsilateral lymphadenopathy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Axillary pain | ✓ | ✓ | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release